CU20140101A7 - MONOCLONAL ANTIBODY ISOLATED FOR PROTEIN PBP5 - Google Patents

MONOCLONAL ANTIBODY ISOLATED FOR PROTEIN PBP5

Info

Publication number
CU20140101A7
CU20140101A7 CUP2014000101A CU20140101A CU20140101A7 CU 20140101 A7 CU20140101 A7 CU 20140101A7 CU P2014000101 A CUP2014000101 A CU P2014000101A CU 20140101 A CU20140101 A CU 20140101A CU 20140101 A7 CU20140101 A7 CU 20140101A7
Authority
CU
Cuba
Prior art keywords
pbp5
protein
monoclonal antibody
antibody isolated
pbp2a
Prior art date
Application number
CUP2014000101A
Other languages
Spanish (es)
Other versions
CU24180B1 (en
Inventor
Senna José Procópio Moreno
Qufiroz Joâo Luiz Sampaio
Nadia Maria Batoreau
Teixeira Maria Da Glória Martin
Original Assignee
Fundação Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BRPI0914508-7A external-priority patent/BRPI0914508B1/en
Application filed by Fundação Oswaldo Cruz filed Critical Fundação Oswaldo Cruz
Priority claimed from PCT/BR2010/000263 external-priority patent/WO2011017791A1/en
Publication of CU20140101A7 publication Critical patent/CU20140101A7/en
Publication of CU24180B1 publication Critical patent/CU24180B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a anticuerpos monoclonales capaces de reconocer y unirse a proteínas PBP2a y PBP5 y otras proteínas que presentan secuencias homólogas a PBP2a, incluyendo los patógenos Staphylococcus aureus resistentes a meticilina- MRSA y Enterococcus faecalis.The present invention relates to monoclonal antibodies capable of recognizing and binding to PBP2a and PBP5 proteins and other proteins that have sequences homologous to PBP2a, including methicillin-resistant pathogens Staphylococcus aureus-MRSA and Enterococcus faecalis.

CU20140101A 2009-08-10 2010-08-10 MONOCLONAL ANTIBODY ISOLATED FOR PROTEIN PBP5 CU24180B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0914508-7A BRPI0914508B1 (en) 2009-08-10 2009-08-10 Monoclonal Antibodies to PBP2a PROTEIN, AND PHARMACEUTICAL COMPOSITION
PCT/BR2010/000263 WO2011017791A1 (en) 2009-08-10 2010-08-10 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum

Publications (2)

Publication Number Publication Date
CU20140101A7 true CU20140101A7 (en) 2015-01-29
CU24180B1 CU24180B1 (en) 2016-04-25

Family

ID=45896895

Family Applications (2)

Application Number Title Priority Date Filing Date
CU20140101A CU24180B1 (en) 2009-08-10 2010-08-10 MONOCLONAL ANTIBODY ISOLATED FOR PROTEIN PBP5
CU2012000026A CU24095B1 (en) 2009-08-10 2010-08-10 ISOLATED MONOCLONAL ANTIBODY FOR PBP2a PROTEINS

Family Applications After (1)

Application Number Title Priority Date Filing Date
CU2012000026A CU24095B1 (en) 2009-08-10 2010-08-10 ISOLATED MONOCLONAL ANTIBODY FOR PBP2a PROTEINS

Country Status (6)

Country Link
JP (1) JP5785544B2 (en)
CN (1) CN102741281B (en)
AU (1) AU2010282162B2 (en)
CA (1) CA2770771C (en)
CU (2) CU24180B1 (en)
SG (1) SG178346A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3415160B1 (en) * 2014-03-04 2021-08-18 Klinikum der Universität München Polypeptides derived from enterococcus and their use for vaccination and the generation of therapeutic antibodies
CN105315367B (en) * 2014-07-29 2019-01-29 广州瑞博奥生物科技有限公司 For detecting the enzyme linked immunological kit of methicillin-resistant staphylococcus aureus
BR102020016890A2 (en) * 2020-08-19 2022-05-03 Fundação Oswaldo Cruz Protein, polynucleotide, vector, host cell, composition, method of treating a disease, in vitro method of prognosticating multiple sclerosis, and, use of a protein or composition
CN113150139B (en) * 2021-02-01 2022-09-09 深圳市龙华区疾病预防控制中心 A kind of PBP2a monoclonal antibody and its preparation method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003503015A (en) * 1999-05-03 2003-01-28 メダレツクス・インコーポレーテツド Human antibodies to Staphylococcus aureus

Also Published As

Publication number Publication date
CA2770771A1 (en) 2011-02-17
RU2012108941A (en) 2013-09-20
CN102741281B (en) 2015-02-25
AU2010282162B2 (en) 2016-06-02
SG178346A1 (en) 2012-03-29
CU24180B1 (en) 2016-04-25
JP2013501732A (en) 2013-01-17
AU2010282162A8 (en) 2012-05-24
CN102741281A (en) 2012-10-17
AU2010282162A1 (en) 2012-04-05
CA2770771C (en) 2019-12-03
JP5785544B2 (en) 2015-09-30
CU20120026A7 (en) 2012-06-21
HK1176077A1 (en) 2013-07-19
CU24095B1 (en) 2015-04-29

Similar Documents

Publication Publication Date Title
CY1123518T1 (en) HUMAN ENANTI-TAU ANTIBODIES
MX2020001879A (en) ANTIGEN BINDING PROTEINS TARGETING SHARED ANTIGENS.
CO2018002446A2 (en) Thymic stromal lymphopoietin (tslp) binding molecules and methods of using the molecules
CR20120210A (en) LINK PROTEINS TO THE ANTIGEN IL-23 HUMANS
CY1120471T1 (en) Anti-CD70 antibodies
SG159458A1 (en) Novel immunoglobulin-binding proteins with improved specificity
PE20181368A1 (en) STROMAL THYMIC LYMPHOPOYETIN (TSLP) BINDING MOLECULES AND METHODS OF USE OF THE MOLECULES
BR112013020500A2 (en) isolated, recombinant or purified antibody
CR20110400A (en) LINK PROTEINS TO THE HUMAN CGRP RECEIVER
CR20130016A (en) PEPTIDIC ANTIBODIES BETA AMILOIDE ANTI-N3pGlu AND USES OF THE SAME
MX373426B (en) IL-18 BINDING MOLECULES.
EA201291065A1 (en) ANTIBODIES AGAINST VLA-4
AR077756A1 (en) SPECIFIC ANTIBODIES FOR GRAM-POSITIVE BACTERIA
CR20140585A (en) ST2 ANTIGEN UNION PROTEINS
EA201490677A1 (en) BONDING ANTIGEN CD27L PROTEINS
CY1115091T1 (en) SPECIFIC PROTECTION ANTIGEN PROTECTION PROTEINS
ECSP11011445A (en) COMPOSITIONS AND METHODS FOR ANTIBODIES THAT ARE DIRECTED TO COMPLEMENT PROTEIN C3B
EA201390146A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9
CO6351750A2 (en) COMPOSITIONS AND METHODS FOR ANTIBODIES THAT GO TO THE COMPLEMENT PROTEIN C5
MX347954B (en) Antibody drug conjugates (adc) that bind to 191p4d12 proteins.
MX2017015817A (en) Tau-binding antibodies.
EA201500503A1 (en) ANTI-HER3 / HER4 ANTIGEN-BINDING PROTEINS CONNECTING A HER3 BETA HAIR AND HER4 BETA HEEL
MX2010006767A (en) HEPATITIS C. VIRUS ANTIBODIES
MX2010004910A (en) RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLONIC AND PANCREATIC CANCERES.
EA201491575A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9

Legal Events

Date Code Title Description
FG Grant of patent